Skip to main content
TipRanks
Go Ultimate75% OFF

Bicara Therapeutics Inc. (BCAX) Q4 2025 Earnings Report

93 Followers

BCAX Q4 2025 EPS Results

Actual EPS
-$0.68
Consensus EPS
-$0.67
Beat/Miss
Missed by -$0.01
One Year Ago EPS
-$0.39

BCAX Q4 2025 Revenue Results

Actual Revenue
$0
Expected Revenue
$0
Beat/Miss
Met expectations
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q4 2025
Date
03/30/2026
Time
Before Open
Conference Call
Monday, March 30, 2026
BCAX Upcoming Earnings

Bicara Therapeutics Inc.'s next earnings date is estimated for April 1, 2027, based on past reporting schedules.

Q4 2025 Earnings Call Audio

BCAX Q4 2025 Earnings Call
0:00 / 0:00

Q4 2025 Earnings Slide Deck

Q4 2025 Earnings Call Summary

No earnings call summary is available for this earnings event.

BCAX Earnings History

BCAX earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Apr 01, 20272026 (Q4)-1.05--0.93――
Nov 09, 20262026 (Q3)-0.82-1.04-0.67-55.22% (-0.37)
Aug 11, 20262026 (Q2)-0.82-0.82-0.5-64.00% (-0.32)
May 11, 20262026 (Q1)-0.65-0.93-0.68-36.76% (-0.25)
Mar 30, 20262025 (Q4)-0.67-0.68-0.39-74.36% (-0.29)
Nov 18, 20252025 (Q3)-0.54-0.67-1.658.13% (+0.93)
Aug 12, 20252025 (Q2)-0.55-0.50-0.45-11.11% (-0.05)
May 13, 20252025 (Q1)-0.41-0.68――
Mar 27, 20252024 (Q4)-0.33-0.39――
Nov 12, 20242024 (Q3)-0.41-1.60-0.42-280.95% (-1.18)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed